Acelyrin

Affibody gets izokibep ‘back on track’ after Acelyrin rejection

Affibody may not have expected to be working on izokibep again, but the Swedish biotech hasn’t wasted an opportunity to showcase the drug’s potential.

James Waldron Jun 5, 2026 10:42am

merge MA railway train tracks path together

Activist investor fails to derail Alumis' Acelyrin merger

May 14, 2025 7:45am

Graphic image of a red thumbs down against a blue background

Investor pressures Acelyrin to exit Alumis merger and liquidate

Apr 30, 2025 10:30am

Pliant, Acelyrin take ‘poison pills’ as Concentra buyout looms

Mar 14, 2025 10:01am

Acelyrin turns down surprise Concentra buyout offer

Mar 4, 2025 10:26am

illustration of two arrows going in opposite directions

Concentra curveball intrudes on Acelyrin-Alumis merger

Feb 21, 2025 7:35am